Adaptimmune and Cryoport announce agreement transport of Adaptimmune’s cell therapies
Adaptimmune and Cryoport, the world's leading temperature-controlled logistics solutions company dedicated to the life sciences industry, announce a 3-year agreement to ensure safe and fully monitored transport of Adaptimmune’s cell therapies. October 09, 2019